China Everbright (SEHK:165) has warned investors of a sharp earnings setback. The company expects profit attributable to shareholders for the first half of 2026 to be 70% to 80% lower than the HK$399 million reported a year earlier.
See our latest analysis for China Everbright.
China Everbright's latest earnings warning lands after a mixed share price pattern, with a 10.66% 1 month share price return contrasting with a year to date share price decline of 36.05% and a 1 year total shareholder return of 19.80% loss. Recent financing activity, including the July issuance of RMB 3b in medium term notes to refinance existing debt, sits against this weaker recent performance and may reflect investors reassessing both earnings risk and balance sheet flexibility at the current HK$6.075 share price.
If this kind of earnings reset has you reassessing your portfolio, it can help to widen the lens and look at other stocks through one consistent framework such as the Simply Wall St screener for 107 top founder-led companies
China Everbright's sharp earnings guidance cut and recent share price swings could reflect deeper issues in the underlying business, or a rapid reset in sentiment. To assess that, it helps to see what the current valuation actually implies.
Preferred Price-to-Sales of 7.7x: Is It Justified?
On the latest figures, China Everbright trades on a P/S ratio of 7.7x, which sits against a last close of HK$6.075 and points to a rich valuation compared with peers.
The P/S ratio compares a company’s share price to its revenue per share. For a diversified financial services group like China Everbright, this tool is often used when earnings are volatile or loss making, as it anchors the valuation to revenue rather than profit.
In this case the multiple is being applied to a business that reported HK$1,321.498m of revenue alongside a loss attributable to shareholders of HK$2,007.723m. That combination suggests the market is attaching a relatively high value to each dollar of sales even though the company is currently unprofitable and has seen earnings decline by 30.1% per year over the past 5 years.
The premium stands out even more when set against the Hong Kong Capital Markets industry. China Everbright’s 7.7x P/S compares with an industry average of 3.7x and a peer average of 6.7x, indicating a higher valuation than both the broader sector and closer comparables.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-Sales of 7.7x (OVERVALUED)
However, China Everbright still faces the risk that continued losses or weaker fund performance could pressure its high price-to-sales (P/S) multiple and limit funding flexibility.
Find out about the key risks to this China Everbright narrative.
Next Steps
Given the cautious tone around China Everbright, it makes sense to look at the underlying data yourself and decide how serious the issues feel for you as an investor. To go deeper into the risk picture, start by reviewing the 1 important warning sign.
Looking for more investment ideas beyond China Everbright?
If China Everbright's situation has you reassessing your options, it makes sense to scan other stocks using a consistent, data driven framework before making your next move.
- Target resilient cash generators by reviewing companies in the 254 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect their financial strength.
- Prioritise capital protection by focusing on companies highlighted in the 306 resilient stocks with low risk scores that score well on balance sheet strength and stability measures.
- Spot potential future leaders by checking the screener containing 538 high quality undiscovered gems that combine solid fundamentals with relatively low current market attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com